PRKCA and glioblastoma: Interestingly, in vitro experiments using U87MG cells showed that loss of PKCα proteins inhibited cell growth or survival, but the same effects were not obtained by inhibiting PKCα activity, indicating that ATP-competitive inhibitors of PKCα may have little or no therapeutic effect in glioblastoma [80].